WAYHELOVÁ, Markéta, Aneta MIKULÁŠOVÁ, Jan SMETANA, Vladimíra VALLOVÁ, Dita BLAŽKOVÁ, Hana FILKOVÁ, Lucie MOUKOVÁ and Petr KUGLÍK. Detection of oncogenic mutations in cervical carcinoma using method "High Resolution Melting" (HRM). Neoplasma. Slovenská akademie vied, vol. 63, No 5, p. 779-788. ISSN 0028-2685. doi:10.4149/neo_2016_516. 2016.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Detection of oncogenic mutations in cervical carcinoma using method "High Resolution Melting" (HRM).
Authors WAYHELOVÁ, Markéta (203 Czech Republic, belonging to the institution), Aneta MIKULÁŠOVÁ (203 Czech Republic, belonging to the institution), Jan SMETANA (203 Czech Republic, belonging to the institution), Vladimíra VALLOVÁ (703 Slovakia, belonging to the institution), Dita BLAŽKOVÁ (203 Czech Republic), Hana FILKOVÁ (203 Czech Republic), Lucie MOUKOVÁ (203 Czech Republic) and Petr KUGLÍK (203 Czech Republic, belonging to the institution).
Edition Neoplasma, Slovenská akademie vied, 2016, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.871
RIV identification code RIV/00216224:14310/16:00090707
Organization unit Faculty of Science
Doi http://dx.doi.org/10.4149/neo_2016_516
UT WoS 000385211400016
Keywords in English Sanger sequencing.; cervical carcinoma; high resolution melting; mutation
Tags AKR, rivok
Changed by Changed by: Ing. Andrea Mikešková, učo 137293. Changed: 3/4/2017 11:54.
Abstract
Oncogenic mutations in proto-oncogenes and tumor suppressor genes represent one of key events in cancerogenesis. In this study, we analysed mutation status in PIK3CA, KRAS and EGFR proto-oncogenes and TP53 tumor suppressor gene in a cohort of twenty-four patients diagnosed with squamous cell carcinoma or adenocarcinoma using the screening method "High Resolution Melting" (HRM). Positive findings were confirmed and identified by Sanger sequencing. Totally, we detected DNA sequence changes in targeted regions in seven patients (7/24, 29.2%). In PIK3CA gene, we found six sequence changes in four patients (4/24, 16.7%) and four of them were confirmed as oncogenic mutations. In KRAS gene, we detected sequence changes in four patients (4/24, 16.7%). Conversely, we identified pathogenic or potentially pathogenic sequence changes neither in EGFR nor TP53 genes. Our results suggest that sequence changes are specific neither for a certain histological subtype, clinical stage nor lymph node involvement and they appear independently on the presence of HPV (human papillomavirus) infection since early clinical stages. We observed the correlation between the presence of DNA sequence changes and hTERC gene amplification, but we did not find a significant relationship between the identified DNA sequence changes and detected copy-number alterations using the technique of array-CGH (array-based comparative genomic hybridization). Regardless our results confirmed an important role of oncogenic mutations in PIK3CA and KRAS genes in the neoplastic transformation process in the cervical carcinoma pathogenesis. Their identification in the early clinical stages should encourage further studies to better understand these mutations and exploit them for more detailed diagnostics.
Links
EE2.3.20.0183, research and development projectName: Centrum experimentální biomedicíny
PrintDisplayed: 19/4/2024 00:54